Cargando…

Recalling the COVID-19 lockdown: Insights from patients with epilepsy

PURPOSE: The purpose of our study was to explore health changes among people with epilepsy (PWE) during a national COVID-19 lockdown in the context of patients’ clinical characteristics and their experience of receiving epilepsy-related medical services. METHODS: A questionnaire was distributed for...

Descripción completa

Detalles Bibliográficos
Autores principales: Puteikis, Kristijonas, Jasionis, Arminas, Mameniškienė, Rūta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700727/
https://www.ncbi.nlm.nih.gov/pubmed/33268021
http://dx.doi.org/10.1016/j.yebeh.2020.107573
_version_ 1783616346848755712
author Puteikis, Kristijonas
Jasionis, Arminas
Mameniškienė, Rūta
author_facet Puteikis, Kristijonas
Jasionis, Arminas
Mameniškienė, Rūta
author_sort Puteikis, Kristijonas
collection PubMed
description PURPOSE: The purpose of our study was to explore health changes among people with epilepsy (PWE) during a national COVID-19 lockdown in the context of patients’ clinical characteristics and their experience of receiving epilepsy-related medical services. METHODS: A questionnaire was distributed for adult PWE both online and at a tertiary epilepsy center after the end of a national lockdown in Lithuania. PWE were asked to evaluate their health status during the lockdown and estimate changes in their seizure patterns. Additional questions concerned the accessibility and quality of epilepsy-related consultations. RESULTS: The study sample consisted of 143 PWE (59 [41.3%] male, mean age 35.1 ± 13.4 years), 94 (65.7%) completed the survey in person, 49 (34.3%) – online. A deterioration in reported physical and mental health during lockdown was observed (Z = −4.604, p < 0.0001 and Z = −4.253, p < 0.0001, respectively) and 22 (15.4%) PWE reported seizure exacerbation. In an ordinal logistic regression model (analysis of data from all participants), baseline seizure frequency (b = 0.413, p = 0.031), reported physical health before lockdown (b = −0.462, p = 0.031) and the ease of proper antiepileptic drug (AED) use during the imposed restrictions (b = −0.535, p = 0.006) were statistically significant variables associated with changes in seizure frequency. The latter were not affected by modifications in AED use (Mann–Whitney U = 1127.0, p = 0.307) irrespective of the data collection method. With teleconsultations being predominant during the lockdown, an overall decline in the quality of epilepsy-related consultations was observed (Z = −2.895, p = 0.004). Among all participants, 46 (32.2%) lost an epilepsy-related consultation or medical service because of the lockdown. This loss was found to be associated with seizure exacerbation (Mann–Whitney U = 1622.5, p = 0.046). CONCLUSION: Our study indicates that a national COVID-19 lockdown may have led to worse seizure control and health status in some PWE. Easy access to AEDs and their appropriate use may be especially useful to prevent seizure exacerbation during strict COVID-19 restrictions. The quality and accessibility of remote epilepsy-related consultations was suboptimal and may require further improvement during disruption of in-person services.
format Online
Article
Text
id pubmed-7700727
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-77007272020-12-01 Recalling the COVID-19 lockdown: Insights from patients with epilepsy Puteikis, Kristijonas Jasionis, Arminas Mameniškienė, Rūta Epilepsy Behav Article PURPOSE: The purpose of our study was to explore health changes among people with epilepsy (PWE) during a national COVID-19 lockdown in the context of patients’ clinical characteristics and their experience of receiving epilepsy-related medical services. METHODS: A questionnaire was distributed for adult PWE both online and at a tertiary epilepsy center after the end of a national lockdown in Lithuania. PWE were asked to evaluate their health status during the lockdown and estimate changes in their seizure patterns. Additional questions concerned the accessibility and quality of epilepsy-related consultations. RESULTS: The study sample consisted of 143 PWE (59 [41.3%] male, mean age 35.1 ± 13.4 years), 94 (65.7%) completed the survey in person, 49 (34.3%) – online. A deterioration in reported physical and mental health during lockdown was observed (Z = −4.604, p < 0.0001 and Z = −4.253, p < 0.0001, respectively) and 22 (15.4%) PWE reported seizure exacerbation. In an ordinal logistic regression model (analysis of data from all participants), baseline seizure frequency (b = 0.413, p = 0.031), reported physical health before lockdown (b = −0.462, p = 0.031) and the ease of proper antiepileptic drug (AED) use during the imposed restrictions (b = −0.535, p = 0.006) were statistically significant variables associated with changes in seizure frequency. The latter were not affected by modifications in AED use (Mann–Whitney U = 1127.0, p = 0.307) irrespective of the data collection method. With teleconsultations being predominant during the lockdown, an overall decline in the quality of epilepsy-related consultations was observed (Z = −2.895, p = 0.004). Among all participants, 46 (32.2%) lost an epilepsy-related consultation or medical service because of the lockdown. This loss was found to be associated with seizure exacerbation (Mann–Whitney U = 1622.5, p = 0.046). CONCLUSION: Our study indicates that a national COVID-19 lockdown may have led to worse seizure control and health status in some PWE. Easy access to AEDs and their appropriate use may be especially useful to prevent seizure exacerbation during strict COVID-19 restrictions. The quality and accessibility of remote epilepsy-related consultations was suboptimal and may require further improvement during disruption of in-person services. Published by Elsevier Inc. 2021-02 2020-11-29 /pmc/articles/PMC7700727/ /pubmed/33268021 http://dx.doi.org/10.1016/j.yebeh.2020.107573 Text en © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Puteikis, Kristijonas
Jasionis, Arminas
Mameniškienė, Rūta
Recalling the COVID-19 lockdown: Insights from patients with epilepsy
title Recalling the COVID-19 lockdown: Insights from patients with epilepsy
title_full Recalling the COVID-19 lockdown: Insights from patients with epilepsy
title_fullStr Recalling the COVID-19 lockdown: Insights from patients with epilepsy
title_full_unstemmed Recalling the COVID-19 lockdown: Insights from patients with epilepsy
title_short Recalling the COVID-19 lockdown: Insights from patients with epilepsy
title_sort recalling the covid-19 lockdown: insights from patients with epilepsy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700727/
https://www.ncbi.nlm.nih.gov/pubmed/33268021
http://dx.doi.org/10.1016/j.yebeh.2020.107573
work_keys_str_mv AT puteikiskristijonas recallingthecovid19lockdowninsightsfrompatientswithepilepsy
AT jasionisarminas recallingthecovid19lockdowninsightsfrompatientswithepilepsy
AT mameniskieneruta recallingthecovid19lockdowninsightsfrompatientswithepilepsy